CA2307194A1 - Gingko biloba de qualite pharmaceutique - Google Patents

Gingko biloba de qualite pharmaceutique Download PDF

Info

Publication number
CA2307194A1
CA2307194A1 CA002307194A CA2307194A CA2307194A1 CA 2307194 A1 CA2307194 A1 CA 2307194A1 CA 002307194 A CA002307194 A CA 002307194A CA 2307194 A CA2307194 A CA 2307194A CA 2307194 A1 CA2307194 A1 CA 2307194A1
Authority
CA
Canada
Prior art keywords
ginkgo
bioactivity
pharmaceutical grade
fingerprint
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002307194A
Other languages
English (en)
Inventor
Tasneem A. Khwaja
Elliot P. Friedman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaPrint Inc
University of Southern California USC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2307194A1 publication Critical patent/CA2307194A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention a trait de manière générale à des matières de gingko et à des procédés de transformation de ces matières en formes utiles d'un point de vue médicinal et pharmaceutiquement acceptables. Plus particulièrement, l'invention a trait à l'utilisation d'empreintes de composition et d'activité dans le traitement de matières de gingko pour produire des médicaments qui remplissent les conditions requises pour constituer des compositions de qualité pharmaceutique convenant pour un usage clinique ou vétérinaire en vue de traiter et/ou soulager des maladies, des affections ou des états pathologiques.
CA002307194A 1997-10-23 1998-10-23 Gingko biloba de qualite pharmaceutique Abandoned CA2307194A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95660097A 1997-10-23 1997-10-23
US08/956,600 1997-10-23
PCT/US1998/022506 WO1999020291A2 (fr) 1997-10-23 1998-10-23 Gingko biloba de qualite pharmaceutique

Publications (1)

Publication Number Publication Date
CA2307194A1 true CA2307194A1 (fr) 1999-04-29

Family

ID=25498427

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002307194A Abandoned CA2307194A1 (fr) 1997-10-23 1998-10-23 Gingko biloba de qualite pharmaceutique

Country Status (6)

Country Link
EP (1) EP1027603A2 (fr)
JP (1) JP2002515402A (fr)
CN (1) CN1290349A (fr)
AU (1) AU1363399A (fr)
CA (1) CA2307194A1 (fr)
WO (1) WO1999020291A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1009437C2 (nl) * 1998-06-18 1999-12-21 Xenobiosis Extractiewerkwijze.
US20030044846A1 (en) 2001-04-03 2003-03-06 Gary Eldridge Screening of chemical compounds purified from biological sources
WO2001033193A2 (fr) * 1999-11-02 2001-05-10 Sequoia Sciences, Inc. Procede automatise d'extraction vegetale et jeu ordonnes d'echantillons destines au criblage a debit eleve
JP2007246507A (ja) * 2006-02-15 2007-09-27 Kracie Seiyaku Kk 疲労の予防・治療組成物及び予防・治療方法
CN110433157B (zh) * 2018-05-02 2022-10-18 成都百裕制药股份有限公司 银杏萜内酯在制备预防和/或治疗眩晕症的药物中的用途
CN109053417B (zh) * 2018-07-27 2021-03-05 山东省分析测试中心 一种高纯度银杏酸的制备方法
CN115141169B (zh) * 2021-03-30 2023-09-08 成都百裕制药股份有限公司 一种萜内酯衍生物及其在医药上的应用
CN113533270A (zh) * 2021-06-16 2021-10-22 万邦德制药集团有限公司 一种银杏叶滴丸的质量控制方法
CN117815223A (zh) * 2024-03-06 2024-04-05 北京市肿瘤防治研究所 银杏双黄酮在制备抗食管鳞癌药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940091A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
US6379714B1 (en) * 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
EP0824355A4 (fr) * 1995-04-14 1998-12-30 Univ Southern California Extrait de gui et compose correspondant

Also Published As

Publication number Publication date
WO1999020291A9 (fr) 1999-08-12
CN1290349A (zh) 2001-04-04
EP1027603A2 (fr) 2000-08-16
JP2002515402A (ja) 2002-05-28
WO1999020291A3 (fr) 1999-07-08
AU1363399A (en) 1999-05-10
WO1999020291A2 (fr) 1999-04-29

Similar Documents

Publication Publication Date Title
US6039950A (en) Pharmaceutical grade saw palmetto
US6113907A (en) Pharmaceutical grade St. John's Wort
CA2307614A1 (fr) Echinacee de qualite pharmaceutique
Ribnicky et al. Evaluation of botanicals for improving human health
CN109444290B (zh) 车前草药材uplc特征图谱的构建方法和检测方法
Mutreja et al. Effect of Nelumbo nucifera seeds on the reproductive organs of female rats
Gurning et al. Identification of secondary metabolites and antidiarrheal activity of pirdot leaves ethanol extract (Saurauia vulcani korth.) from West Pakpak, North Sumatera Province, Indonesia
CA2307194A1 (fr) Gingko biloba de qualite pharmaceutique
WO1999021008A1 (fr) Ail de qualite pharmaceutique
WO1999020292A1 (fr) Ginseng de qualite pharmaceutique
Ahmad et al. Phytochemical and pharmacological studies on methanolic seeds' extract of Dolichos biflorus.
WO1999021006A9 (fr) Valeriane, actee a grappes, vitex agnus-castus, airelle et chardon-marie de qualite pharmaceutique
CN103169782B (zh) 一种调胃承气汤配方颗粒及其制备方法和检测方法
CA2306818A1 (fr) Millepertuis de qualite pharmaceutique
Shrivastava et al. Extensive review on the analytical methods for the estimation of Thuja occidentalis homeopathic mother tincture
Satchithanandam et al. Alkaloids and saponins in dietary supplements of blue cohosh (Caulophyllum thalictroides)
RU2782620C1 (ru) Способ количественного определения сирингина в коре сирени обыкновенной
Gryszczyńska et al. Comparison of phenylethanoids content in Rhodiola kirilowii and Rhodiola rosea roots applying a newly developed UPLC-MS/MS method
Anokwuru Phytochemical, biological and toxicity studies of Terminalia sericea Burch.(Combretaceae)
CN113295807A (zh) 蛇莓药材中没食子酸含量的测定方法及蛇莓药材质量控制方法
SOTENJWA PHYTOCHEMICAL VARIATION AND QUALITY CONTROL OF NON-VOLATILE CONSTITUENTS OF ARTEMISIA AFRA
CN101625348B (zh) 驴胶补血制剂及其原料、中间体的指纹图谱测定方法
Sidametova Formulation development and establishment of quality standards of sedative drug" Flegmen"
Chen et al. Highly Effectively Evaluating the quality consistency ofDihuang Pills by Quantified both HPLC and IR profilesthat assisted by antioxidant activity
Vinay et al. HPTLC finger print profile of n-hexane extract of Rauwolfia tetraphylla Linn

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20021023